Gk. Klintworth et al., MACULAR CORNEAL-DYSTROPHY IN SAUDI-ARABIA - A STUDY OF 56 CASES AND RECOGNITION OF A NEW IMMUNOPHENOTYPE, American journal of ophthalmology, 124(1), 1997, pp. 9-18
PURPOSE: To determine the immunophenotype or immunophenotypes of macul
ar corneal dystrophy in Saudi Arabia. METHODS: We studied 56 cases of
macular corneal dystrophy. Tissue from 60 corneal trans plant buttons
was stained by the avidin-biotin complex method using an anti-keratan
sulfate monoclonal antibody. The serum antigenic keratan sulfate was m
easured in 23 of the 56 patients, four unaffected relatives, and 13 in
dividuals with chronic actinic keratopathy. Serum and corneal tissue w
ere studied in 17 of the 50 affected individuals with corneal transpla
nt material. RESULTS: Thirty-five corneas (58.3%) of 29 of 50 patients
did not react with anti-keratan sulfate monoclonal antibody. The stro
ma and abnormal intracellular and extracellular corneal accumulations
reacted with anti-keratan sulfate monoclonal antibody in seven corneas
(11.7%). The stroma in the other 18 corneas (30.0%) from 15 patients
did not react with the anti-keratan sulfate monoclonal antibody, but c
orneal fibroblasts did. Twenty-one of the 23 patients with macular cor
neal dystrophy had no detectable serum antigenic keratan sulfate (<9 n
g/ml); two had values of 12 and 51 ng/ml, respectively, and their corn
eal stroma and abnormal accumulations reacted with anti-keratan sulfat
e monoclonal antibody. CONCLUSIONS: We detected macular corneal dystro
phy type IA, a new immunophenotype characterized by the lack of detect
able antigenic keratan sulfate in the serum (<9 ng/ml), and a corneal
stroma that did not react: with the keratan sulfate monoclonal antibod
y but in which corneal fibroblasts did react with keratan sulfate mono
clonal antibody (in 15 of 50 patients).